secwatch.observer — SEC 8-K summary
======================================

Issuer:     HALOZYME THERAPEUTICS, INC. (HALO)
CIK:        0001159036
Form:       8-K
Filed at:   2021-12-13T23:59:59+00:00
Accession:  0001159036-21-000059
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Halozyme appoints Mark Snyder as General Counsel; Matsuda steps down Dec 31
---------------------------------------------------------------------------

- Masaru Matsuda steps down as SVP, General Counsel, Chief Compliance Officer and Corporate Secretary effective Dec 31, 2021 to pursue another opportunity.
- Mark Snyder appointed to those roles effective Jan 3, 2022; previously SVP, Deputy General Counsel, Litigation at Qualcomm.
- Snyder brings nearly 30 years of legal experience, including IP, licensing, regulatory, antitrust, and litigation.
- Company expects to enter a separation agreement with Matsuda with benefits consistent with those disclosed in 2018 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1159036/000115903621000059/0001159036-21-000059-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1159036/000115903621000059/halo-20211213.htm
  HTML page:      https://secwatch.observer/filing/0001159036-21-000059

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer